Schneider Jennifer sold VRTX
May 1, 2026 · Form 4 insider transaction
Schneider Jennifer sold 796 shares of Vertex Pharmaceuticals Incorporated, a transaction worth N/A. The trade was recorded as disposition to the issuer and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Disposed (sell-side)
Shares
796
Price
N/A
Total value
N/A
InsiderSchneider Jennifer
Role—
SecurityCommon Stock
Transaction codeD: Disposition to the issuer
Transaction dateMay 1, 2026
Filing dateMay 5, 2026
Shares owned after1,394
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Upon the vesting of restricted stock units granted to Dr. Schneider on May 1, 2025, Dr. Schneider deferred the receipt of 796 shares of common stock and received instead 796 deferred stock units pursuant to our deferred compensation plan. As a result, Dr. Schneider is reporting the disposition of 796 shares of common stock in exchange for an equal number of deferred stock units.